{"entity":{"type":"insider","cik":"0001291963","url":"/insider/0001291963","json_url":"/insider/0001291963.json","name":"Greene Barry E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":124,"n_filings":34,"first":"2004-08-27","last":"2022-11-15","span_basis":"filed_date"},"name_variants":[{"name":"Greene Barry E","source":"filing","n_filings":34,"first_seen":"2004-08-27","last_seen":"2022-11-15"}],"transactions":[{"id":6133003,"accession":"0001562180-22-007667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-007667","line_url":"/filing/0001562180-22-007667#line-1","is_derivative":false,"issuer_cik":"0001291963","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001291963","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14500.0,"shares_display":"14,500","price_per_share":34.4843,"price_display":"34.48","price_state":"stated","total_value":500022.35,"total_display":"500,022.35","total_whole":"500,022","shares_owned_after":46940.0,"shares_owned_after_display":"46,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-15","scope":"insider"},{"id":4698196,"accession":"0001562180-21-005226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-005226","line_url":"/filing/0001562180-21-005226#line-1","is_derivative":false,"issuer_cik":"0001291963","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001291963","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23640.0,"shares_display":"23,640","price_per_share":43.1495,"price_display":"43.15","price_state":"stated","total_value":1020054.18,"total_display":"1,020,054.18","total_whole":"1,020,054","shares_owned_after":32440.0,"shares_owned_after_display":"32,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-09","scope":"insider"},{"id":4522307,"accession":"0001562180-21-004342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-004342","line_url":"/filing/0001562180-21-004342#line-1","is_derivative":false,"issuer_cik":"0001291963","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001291963","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8800.0,"shares_display":"8,800","price_per_share":56.3213,"price_display":"56.32","price_state":"stated","total_value":495627.44,"total_display":"495,627.44","total_whole":"495,627","shares_owned_after":8800.0,"shares_owned_after_display":"8,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-17","scope":"insider"},{"id":2961653,"accession":"0001735276-20-000098","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-20-000098","line_url":"/filing/0001735276-20-000098","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44530.0,"shares_display":"44,530","price_per_share":123.23365124635077,"price_display":"123.23","price_state":"stated","total_value":5487594.49,"total_display":"5,487,594.49","total_whole":"5,487,594","shares_owned_after":73689.0,"shares_owned_after_display":"73,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-11","scope":"insider","n_lines":3},{"id":2551133,"accession":"0001735276-20-000084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-20-000084","line_url":"/filing/0001735276-20-000084#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22265.0,"shares_display":"22,265","price_per_share":159.99,"price_display":"159.99","price_state":"stated","total_value":3562177.35,"total_display":"3,562,177.35","total_whole":"3,562,177","shares_owned_after":62236.0,"shares_owned_after_display":"62,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":2232999,"accession":"0001735276-20-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-20-000060","line_url":"/filing/0001735276-20-000060#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22265.0,"shares_display":"22,265","price_per_share":149.99,"price_display":"149.99","price_state":"stated","total_value":3339527.35,"total_display":"3,339,527.35","total_whole":"3,339,527","shares_owned_after":62236.0,"shares_owned_after_display":"62,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-07","scope":"insider"},{"id":8304072,"accession":"0001735276-19-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-19-000094","line_url":"/filing/0001735276-19-000094#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58913.0,"shares_display":"58,913","price_per_share":89.99,"price_display":"89.99","price_state":"stated","total_value":5301580.87,"total_display":"5,301,580.87","total_whole":"5,301,581","shares_owned_after":52938.0,"shares_owned_after_display":"52,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-22","filed_date":"2019-10-24","scope":"insider"},{"id":6841705,"accession":"0001553878-18-000026","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001553878-18-000026","line_url":"/filing/0001553878-18-000026","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38460.0,"shares_display":"38,460","price_per_share":143.10285361414458,"price_display":"143.10","price_state":"stated","total_value":5503735.75,"total_display":"5,503,735.75","total_whole":"5,503,736","shares_owned_after":81077.0,"shares_owned_after_display":"81,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-16","scope":"insider","n_lines":6},{"id":4466420,"accession":"0001553878-17-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-17-000054","line_url":"/filing/0001553878-17-000054#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85316.0,"shares_display":"85,316","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":10664500.0,"total_display":"10,664,500.00","total_whole":"10,664,500","shares_owned_after":100428.0,"shares_owned_after_display":"100,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":5080671,"accession":"0001553878-17-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-17-000047","line_url":"/filing/0001553878-17-000047#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76815.0,"shares_display":"76,815","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":7681500.0,"total_display":"7,681,500.00","total_whole":"7,681,500","shares_owned_after":88584.0,"shares_owned_after_display":"88,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-20","filed_date":"2017-09-22","scope":"insider"},{"id":4743052,"accession":"0001209191-17-047299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-047299","line_url":"/filing/0001209191-17-047299#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.5697,"price_display":"21.57","price_state":"stated","total_value":215697.0,"total_display":"215,697.00","total_whole":"215,697","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-01","filed_date":"2017-08-03","scope":"insider"},{"id":5060197,"accession":"0001209191-17-009970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-009970","line_url":"/filing/0001209191-17-009970#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":723.0,"shares_display":"723","price_per_share":22.65,"price_display":"22.65","price_state":"stated","total_value":16375.95,"total_display":"16,375.95","total_whole":"16,376","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-13","scope":"insider"},{"id":4193980,"accession":"0001209191-17-001997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-001997","line_url":"/filing/0001209191-17-001997#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3017.0,"shares_display":"3,017","price_per_share":19.2618,"price_display":"19.26","price_state":"stated","total_value":58112.8506,"total_display":"58,112.85","total_whole":"58,113","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":2876542,"accession":"0001553878-16-000061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-16-000061","line_url":"/filing/0001553878-16-000061","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31825.0,"shares_display":"31,825","price_per_share":42.9890849520817,"price_display":"42.99","price_state":"stated","total_value":1368127.6286,"total_display":"1,368,127.63","total_whole":"1,368,128","shares_owned_after":89084.0,"shares_owned_after_display":"89,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider","n_lines":3},{"id":8431364,"accession":"0001553878-15-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-15-000025","line_url":"/filing/0001553878-15-000025#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67379.0,"shares_display":"67,379","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":8422375.0,"total_display":"8,422,375.00","total_whole":"8,422,375","shares_owned_after":23392.0,"shares_owned_after_display":"23,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-26","filed_date":"2015-05-28","scope":"insider"},{"id":8847010,"accession":"0001209191-15-032734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-032734","line_url":"/filing/0001209191-15-032734#line-1","is_derivative":false,"issuer_cik":"0001291963","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001291963","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":29.3128,"price_display":"29.31","price_state":"stated","total_value":87938.4,"total_display":"87,938.40","total_whole":"87,938","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-02","filed_date":"2015-04-06","scope":"insider"},{"id":6196167,"accession":"0001553878-14-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001553878-14-000038","line_url":"/filing/0001553878-14-000038#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11200.0,"shares_display":"11,200","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":1120000.0,"total_display":"1,120,000.00","total_whole":"1,120,000","shares_owned_after":22392.0,"shares_owned_after_display":"22,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2014-12-22","scope":"insider"},{"id":6714172,"accession":"0001553878-14-000021","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001553878-14-000021","line_url":"/filing/0001553878-14-000021","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33200.0,"shares_display":"33,200","price_per_share":89.63191910843373,"price_display":"89.63","price_state":"stated","total_value":2975779.7144,"total_display":"2,975,779.71","total_whole":"2,975,780","shares_owned_after":48733.0,"shares_owned_after_display":"48,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-19","scope":"insider","n_lines":4},{"id":6293114,"accession":"0001553878-14-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-14-000020","line_url":"/filing/0001553878-14-000020#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11100.0,"shares_display":"11,100","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":1110000.0,"total_display":"1,110,000.00","total_whole":"1,110,000","shares_owned_after":33592.0,"shares_owned_after_display":"33,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-13","scope":"insider"},{"id":4748708,"accession":"0001553878-13-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-13-000005","line_url":"/filing/0001553878-13-000005","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22822.0,"shares_display":"22,822","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":684660.0,"total_display":"684,660.00","total_whole":"684,660","shares_owned_after":4572.0,"shares_owned_after_display":"4,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-28","filed_date":"2013-05-30","scope":"insider","n_lines":2},{"id":4802325,"accession":"0001553878-13-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-13-000003","line_url":"/filing/0001553878-13-000003#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24058.0,"shares_display":"24,058","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":601450.0,"total_display":"601,450.00","total_whole":"601,450","shares_owned_after":4572.0,"shares_owned_after_display":"4,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-14","filed_date":"2013-03-18","scope":"insider"},{"id":5084988,"accession":"0001325812-13-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001325812-13-000003","line_url":"/filing/0001325812-13-000003#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":24.4279,"price_display":"24.43","price_state":"stated","total_value":586269.6,"total_display":"586,269.60","total_whole":"586,270","shares_owned_after":4572.0,"shares_owned_after_display":"4,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-08","filed_date":"2013-03-11","scope":"insider"},{"id":2226079,"accession":"0001325812-12-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-12-000007","line_url":"/filing/0001325812-12-000007#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1860.0,"shares_display":"1,860","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":19995.0,"total_display":"19,995.00","total_whole":"19,995","shares_owned_after":4572.0,"shares_owned_after_display":"4,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-21","filed_date":"2012-02-23","scope":"insider"},{"id":3547657,"accession":"0001325812-12-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-12-000002","line_url":"/filing/0001325812-12-000002#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":567.0,"shares_display":"567","price_per_share":8.8044,"price_display":"8.80","price_state":"stated","total_value":4992.0948,"total_display":"4,992.09","total_whole":"4,992","shares_owned_after":2712.0,"shares_owned_after_display":"2,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-09","filed_date":"2012-01-11","scope":"insider"},{"id":8913689,"accession":"0001325812-11-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-11-000030","line_url":"/filing/0001325812-11-000030#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":699.0,"shares_display":"699","price_per_share":7.146,"price_display":"7.15","price_state":"stated","total_value":4995.054,"total_display":"4,995.05","total_whole":"4,995","shares_owned_after":2145.0,"shares_owned_after_display":"2,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-12","filed_date":"2011-12-14","scope":"insider"},{"id":8950735,"accession":"0001325812-11-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-11-000023","line_url":"/filing/0001325812-11-000023#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":704.0,"shares_display":"704","price_per_share":7.094,"price_display":"7.09","price_state":"stated","total_value":4994.176,"total_display":"4,994.18","total_whole":"4,994","shares_owned_after":1446.0,"shares_owned_after_display":"1,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-14","filed_date":"2011-11-16","scope":"insider"},{"id":9094157,"accession":"0001325812-11-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-11-000021","line_url":"/filing/0001325812-11-000021#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":742.0,"shares_display":"742","price_per_share":6.7325,"price_display":"6.73","price_state":"stated","total_value":4995.515,"total_display":"4,995.52","total_whole":"4,996","shares_owned_after":742.0,"shares_owned_after_display":"742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-11","filed_date":"2011-10-13","scope":"insider"},{"id":2835518,"accession":"0001325812-08-000039","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001325812-08-000039","line_url":"/filing/0001325812-08-000039","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35440.0,"shares_display":"35,440","price_per_share":33.93696396162528,"price_display":"33.94","price_state":"stated","total_value":1202726.0028,"total_display":"1,202,726.00","total_whole":"1,202,726","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-13","filed_date":"2008-08-15","scope":"insider","n_lines":2},{"id":7988093,"accession":"0001325812-07-000038","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-18","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":31.77,"price_display":"31.77","price_state":"stated","total_value":31770.0,"total_display":"31,770.00","total_whole":"31,770","shares_owned_after":5811.0,"shares_owned_after_display":"5,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7988091,"accession":"0001325812-07-000038","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-17","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.53,"price_display":"31.53","price_state":"stated","total_value":18918.0,"total_display":"18,918.00","total_whole":"18,918","shares_owned_after":7511.0,"shares_owned_after_display":"7,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7988089,"accession":"0001325812-07-000038","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-16","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.38,"price_display":"31.38","price_state":"stated","total_value":18828.0,"total_display":"18,828.00","total_whole":"18,828","shares_owned_after":8871.0,"shares_owned_after_display":"8,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7988088,"accession":"0001325812-07-000038","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.78,"price_display":"31.78","price_state":"stated","total_value":12712.0,"total_display":"12,712.00","total_whole":"12,712","shares_owned_after":5411.0,"shares_owned_after_display":"5,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7988086,"accession":"0001325812-07-000038","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.76,"price_display":"31.76","price_state":"stated","total_value":12704.0,"total_display":"12,704.00","total_whole":"12,704","shares_owned_after":6811.0,"shares_owned_after_display":"6,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7988084,"accession":"0001325812-07-000038","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.4,"price_display":"31.40","price_state":"stated","total_value":12560.0,"total_display":"12,560.00","total_whole":"12,560","shares_owned_after":8411.0,"shares_owned_after_display":"8,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7988083,"accession":"0001325812-07-000038","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":31.8,"price_display":"31.80","price_state":"stated","total_value":9540.0,"total_display":"9,540.00","total_whole":"9,540","shares_owned_after":5111.0,"shares_owned_after_display":"5,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"},{"id":7988081,"accession":"0001325812-07-000038","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001325812-07-000038","line_url":"/filing/0001325812-07-000038#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291963","owner_name":"Greene Barry E","owner_display_name":"Greene Barry E","owner_url":"/insider/0001291963","role":"Officer (COO)","role_mark":"O","role_mark_label":"Officer (COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":31.82,"price_display":"31.82","price_state":"stated","total_value":8273.2,"total_display":"8,273.20","total_whole":"8,273","shares_owned_after":4851.0,"shares_owned_after_display":"4,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-24","filed_date":"2007-10-26","scope":"insider"}],"collapsed":true,"next_cursor":"2007-10-24|7988081","ledger_fault":false,"count":{"value":124,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":112,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":124},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597553","name":"Sage Therapeutics, Inc.","url":"/issuer/0001597553","role":"Director, Officer (President and CEO)","n_filings":3,"first_seen":"2021-06-17","last_seen":"2022-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (President)","n_filings":27,"first_seen":"2004-08-27","last_seen":"2020-09-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Director","n_filings":3,"first_seen":"2017-01-05","last_seen":"2017-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Director","n_filings":1,"first_seen":"2015-04-06","last_seen":"2015-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291963","retrieved_at":"2026-08-22T09:00:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}